BAMF
RVMD icon

BI Asset Management Fondsmaeglerselskab’s Revolution Medicines RVMD Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
6,800
+2,154
+46% +$315K 0.01% 486
2026
Q1 		$452K Buy
+4,646
New +$469K ﹤0.01% 557

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's RVMD Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Revolution Medicines (RVMD) stake by 46% in Q2 2026, buying an estimated $315K and bringing the position to 6,800 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #486.

BI Asset Management Fondsmaeglerselskab first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 390 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 6,800 shares of Revolution Medicines worth $1.27M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 2,154 Revolution Medicines shares in Q2 2026, an estimated $315K.
  • Revolution Medicines made up 0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #486 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 390 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.